Abstract:OBJECTIVE To retrospectively investigate the risk factors associated the mortality of the patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa,and focus on the impact of different antimicrobial regimens on the patients with A.baumannii pneumonia so as to guide the clinical treatment.METHODS We searched the qualified respiratory samples(including sputum and endotracheal aspirate) in the hospital during Jan 2012 to Aug 2012,and identified the cases with A.baumannii and/or P.aeruginosa positive isolates.The clinical data of the cases were reviewed and the cases were recruited when they were clinically diagnosed as pneumonia.The clinical and microbiological data of the patients were collected.logistic regression was applied to identify the risk factors of the mortality.RESULTS Totally 79 patients with pneumonia were enrolled in the study,including 46 patients infected with A.baumannii and 33 patients infected with P.aeruginosa;29 cases died with the mortality of 36.7%;the multivariate regression analysis showed that the respiratory frequency,blood urea nitrogen,sepsis,albumin level and use of antibiotics were the independent risk factors for the mortality of the patients with A.baumannii or P.aeruginosa pneumonia.The mortality of the patients with A.baumannii pneumonia was 50.0%,18.8% of the patients with P.aeruginosa pneumonia(P=0.004);A.baumannii infection was an independent factor for the increase in mortality(OR=4.33,P=0.007).Of all the A.baumannii strains,the multidrug-resistant A.baumannii accounted for 97.8%;the analysis of treatment program indicated that the use of single carbapenem for the primary treatment may increase the risk of mortality and that the use of other antibiotics had no significant impact on the mortality.CONCLUSION The severity of infection is the independent risk factor for the mortality of the patients with A.baumannii or P.aeruginosa pneumonia.The mortality of the patients with A.baumannii infections,especially the multidrug-resistant A.baumannii infections,is high.If A.baumannii infection or multidrug-resistant A.baumannii infection are concerned in clinic,the combination antimicrobial treatment or the compound containing sulbactam should be used as empirical therapy.

Correlation between drug resistance of Pseudomonas aeruginosa causing pneumonia and mortality

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Risk factors and drug resistance analysis of multi-drug resistance Pseudomonas aeruginosa infection in severe acute pancreatitis*

Risk factors for mortality of patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa

Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality

Incidence, antimicrobial resistance and mortality of Pseudomonas aeruginosa bloodstream infections among hospitalized patients in China: a retrospective observational multicenter cohort study from 2017 to 2021

Risk Factors and Clinical Outcomes of Nosocomial Multi-Drug Resistant Pseudomonas Aeruginosa Infections

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies

Risk Factors for Acquisition and Mortality of Multidrug-Resistant Acinetobacter Baumannii Bacteremia

Prevalence and risk factors of multidrug-resistant Pseudomonas aeruginosa pneumonia in intensive care unit

Risk Factors of Clinical Outcomes and Inadequate Initial Antibiotic Therapy with Pneumonia Caused by Pseudomonas Aeruginosa in Intensive Care Unit

A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia

Risk factors for Acinetobacter baumannii hospital-acquired pneumonia and associated mortality

The Prognosis of Acinetobacter Baumannii Infection Associated with Drug Resistance in the Intensive Care Unit

Clinical characteristics and risk factors for mortality in children with Pseudomonas aeruginosa bacteraemia: A retrospective review at a paediatric tertiary centre

Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia

A prediction and interpretation machine learning framework of mortality risk among severe infection patients with pseudomonas aeruginosa

Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing

Clinical analysis of bloodstream infections caused by Pseudomonas aeruginosa

Risk factors for hospital-acquired bloodstream infections caused by gram-positive cocci and analysis of prognosis